AAAAAA

   
Results: 1-16 |
Results: 16
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Authors: Lin, SY Makino, K Xia, WY Matin, A Wen, Y Kwong, KY Bourguignon, L Hung, MC
Citation: Sy. Lin et al., Nuclear localization of EGF receptor and its potential new role as a transcription factor, NAT CELL BI, 3(9), 2001, pp. 802-808
Cytoplasmic localization of p21(Cip1/WAF1) by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
Authors: Zhou, BHP Liao, Y Xia, WY Spohn, B Lee, NH Hung, MC
Citation: Bhp. Zhou et al., Cytoplasmic localization of p21(Cip1/WAF1) by Akt-induced phosphorylation in HER-2/neu-overexpressing cells, NAT CELL BI, 3(3), 2001, pp. 245-252
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
Authors: Zhou, BHP Liao, Y Xia, WY Zou, YY Spohn, B Hung, MC
Citation: Bhp. Zhou et al., HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation, NAT CELL BI, 3(11), 2001, pp. 973-982
DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway
Authors: Wang, SC Makino, K Xia, WY Kim, JS Im, SA Peng, H Mok, SC Singletary, SE Hung, MC
Citation: Sc. Wang et al., DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway, ONCOGENE, 20(47), 2001, pp. 6960-6964
Correlation of p27 protein expression with HER-2/neu expression in breast cancer
Authors: Newman, L Xia, WY Yang, HY Sahin, A Bondy, M Lukmanji, F Hung, MC Lee, MH
Citation: L. Newman et al., Correlation of p27 protein expression with HER-2/neu expression in breast cancer, MOL CARCINO, 30(3), 2001, pp. 169-175
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A phase I clinical trial
Authors: Hortobagyi, GN Ueno, NT Xia, WY Zhang, S Wolf, JK Putnam, JB Weiden, PL Willey, JS Carey, M Branham, DL Payne, JY Tucker, SD Bartholomeusz, C Kilbourn, RG De Jager, RL Sneige, N Katz, RL Anklesaria, P Ibrahim, NK Murray, JL Theriault, RL Valero, V Gershenson, DM Bevers, MW Huang, L Lopez-Berestein, G Hung, MC
Citation: Gn. Hortobagyi et al., Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A phase I clinical trial, J CL ONCOL, 19(14), 2001, pp. 3422-3433
Targeting HER-2/neu-overexpressing breast cancer cells by an antisense iron responsive element-directed gene expression
Authors: Li, Z Xia, WY Fang, BL Yan, DH
Citation: Z. Li et al., Targeting HER-2/neu-overexpressing breast cancer cells by an antisense iron responsive element-directed gene expression, CANCER LETT, 174(2), 2001, pp. 151-158
The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis
Authors: Xing, XM Wang, SC Xia, WY Zou, YY Shao, RP Kwong, KY Yu, ZM Zhang, S Miller, S Huang, L Hung, MC
Citation: Xm. Xing et al., The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis, NAT MED, 6(2), 2000, pp. 189-195
High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma
Authors: Xia, WY Lau, YK Hu, MCT Li, L Johnston, DA Sheng, SJ El-Naggar, AK Hung, MC
Citation: Wy. Xia et al., High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma, ONCOGENE, 19(20), 2000, pp. 2398-2403
beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
Authors: Lin, SY Xia, WY Wang, JC Kwong, KY Spohn, B Wen, Y Pestell, RG Hung, MC
Citation: Sy. Lin et al., beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression, P NAS US, 97(8), 2000, pp. 4262-4266
HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappa B pathway
Authors: Zhou, BP Hu, MCT Miller, SA Yu, ZM Xia, WY Lin, SY Hung, MC
Citation: Bp. Zhou et al., HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappa B pathway, J BIOL CHEM, 275(11), 2000, pp. 8027-8031
The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice
Authors: Xu, FJ Xia, WY Luo, RZ Peng, HQ Zhao, SL Dai, JY Long, Y Zou, LL Le, WD Liu, JS Parlow, AF Hung, MC Bast, RC Yu, YH
Citation: Fj. Xu et al., The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice, CANCER RES, 60(17), 2000, pp. 4913-4920
Inhibition of angiogenesis and induction of apoptosis are involved in E1A-mediated bystander effect and tumor suppression
Authors: Shao, RP Xia, WY Hung, MC
Citation: Rp. Shao et al., Inhibition of angiogenesis and induction of apoptosis are involved in E1A-mediated bystander effect and tumor suppression, CANCER RES, 60(12), 2000, pp. 3123-3126
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel
Authors: Zhang, LS Lau, YK Xia, WY Hortobagyi, GN Hung, MC
Citation: Ls. Zhang et al., Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel, CLIN CANC R, 5(2), 1999, pp. 343-353
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
Authors: Xia, WY Lau, YK Zhang, HZ Xiao, FY Johnston, DA Liu, AR Li, L Katz, RL Hung, MC
Citation: Wy. Xia et al., Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members, CLIN CANC R, 5(12), 1999, pp. 4164-4174
Issues in the development of gene therapy: Preclinical experiments in E1A gene delivery
Authors: Ueno, NT Xia, WY Tucker, SD Zhang, S Lopez-Berestein, G Huang, L Hung, MC
Citation: Nt. Ueno et al., Issues in the development of gene therapy: Preclinical experiments in E1A gene delivery, ONCOL REP, 6(2), 1999, pp. 257-262
Risultati: 1-16 |